611 Shares in HCA Healthcare, Inc. $HCA Acquired by Capital Investment Advisors LLC

Key Points

• Capital Investment Advisors LLC has acquired a new position in HCA Healthcare, Inc., purchasing 611 shares valued at approximately $234,000.
• HCA Healthcare reported a Q2 earnings per share (EPS) of $6.84, exceeding analysts' estimates of $6.20, with a revenue of $18.61 billion.
• The company recently paid a quarterly dividend of $0.72 per share, marking an annualized dividend yield of 0.7% and a payout ratio of 12.11%.

Capital Investment Advisors LLC acquired a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 611 shares of the company's stock, valued at approximately $234,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of HCA Healthcare by 11.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company's stock worth $8,796,000 after purchasing an additional 2,698 shares during the last quarter. Harrell Investment Partners LLC raised its stake in shares of HCA Healthcare by 176.3% in the second quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company's stock worth $695,000 after purchasing an additional 1,158 shares during the last quarter. Brown Advisory Inc. grew its holdings in shares of HCA Healthcare by 53.9% in the first quarter. Brown Advisory Inc. now owns 4,630 shares of the company's stock valued at $1,600,000 after acquiring an additional 1,622 shares in the last quarter. Farther Finance Advisors LLC grew its holdings in shares of HCA Healthcare by 26.9% in the first quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company's stock valued at $395,000 after acquiring an additional 242 shares in the last quarter. Finally, GAMMA Investing LLC grew its holdings in shares of HCA Healthcare by 17.6% in the first quarter. GAMMA Investing LLC now owns 4,931 shares of the company's stock valued at $1,704,000 after acquiring an additional 737 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $429.52 on Friday. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $432.36. The business has a fifty day moving average price of $397.53 and a 200-day moving average price of $372.39. The firm has a market capitalization of $100.50 billion, a P/E ratio of 18.05, a PEG ratio of 1.34 and a beta of 1.40.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same period last year, the company earned $5.50 earnings per share. The business's revenue for the quarter was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is 12.11%.

Insider Activity

In related news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares in the company, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 1.30% of the company's stock.

Analyst Ratings Changes

Several research firms have recently issued reports on HCA. Weiss Ratings reaffirmed a "buy (b-)" rating on shares of HCA Healthcare in a report on Saturday, September 27th. Morgan Stanley reduced their target price on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a report on Monday, July 28th. Robert W. Baird increased their price objective on HCA Healthcare from $380.00 to $423.00 and gave the company a "neutral" rating in a report on Thursday, August 14th. Cantor Fitzgerald reissued an "overweight" rating and set a $444.00 price objective on shares of HCA Healthcare in a report on Tuesday, August 26th. Finally, Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $407.75.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.